OminiWell

Recreating living microtissues in the lab

OminiWell Bioscience

OminiWell Pty Ltd was founded in 2020 by award winning biomedical engineering researcher, Dr Chia-Chi Chien. Dr Chien spent seven years on OminiWell before successfully developing an organ culture platform for growing mini-tissue organs in the lab. She transformed the idea from lab technology to clinical application with the next step to use the unique technology for preclinical and clinical services to speed up the drug discovering processes.

Benefits

Decreases reliance on animal testing
Gives researchers, a more in-depth understanding of drug treatments.

Technology

With everyone’s body reacting differently to complex drug treatments, the future of medicine is largely centred around ‘personalised medicine’. Ominiwell is taking the key elements of a person’s biological system and recreating a ’biological twin’ within a 3D cell structure on a chip for the purpose of optimising and testing personalised drug combinations that will enable the best outcome for patients. OminiWell is growing complex mini organ tissues in the lab that will enable the acceleration of the drug discovery process and reduce the need for animal testing.

Their platform will be used to improve the decisions of medical professionals who are monitoring clinical treatment for personalised medicine and shortening the time for drug discovery.